Journal of perinatology : official journal of the California Perinatal Association · 2026
Short-term outcomes associated with surfactant use in respiratory distress in late preterm to early term infants.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Peterson Catherine, Hassen Kasim, Avila Misciagno Susan, Holland Melissa, Jiroutek Michael R, Katheria Anup
Аннотация
OBJECTIVE: Evaluate surfactant therapy and clinical outcomes including length of hospital stay (LOS), CPAP, and mechanical ventilation in late preterm to early term infants.
STUDY DESIGN: A single-center retrospective study of 401 eligible infants 33-38 + 6 weeks. Surfactant administration included INSURE (INtubation-SURfactant-Extubation), LISA (Less Invasive Surfactant Administration), and endotracheal with prolonged invasive ventilation.
RESULTS: 114 (28%) received surfactant. Surfactant-treated infants had longer LOS (16 ± 11 vs 12 ± 9 days, p < 0.001) compared to non-treated. Infants who received INSURE/LISA (n = 43) had shorter LOS (14 ± 9 vs 18 ± 12 days, p = 0.04) than endotracheal surfactant with prolonged mechanical ventilation (n = 71). Infants who received INSURE/LISA had similar LOS to non-surfactant-treated infants (14 ± 9 vs 13 ± 9 days, p = 0.47).
CONCLUSION: Surfactant administration was associated with longer hospitalization compared to non-treated infants. INSURE/LISA shortened LOS compared to surfactant with prolonged ventilation. In late preterm and early term infants that require surfactant for RDS, less invasive methods reduce LOS.
STUDY DESIGN: A single-center retrospective study of 401 eligible infants 33-38 + 6 weeks. Surfactant administration included INSURE (INtubation-SURfactant-Extubation), LISA (Less Invasive Surfactant Administration), and endotracheal with prolonged invasive ventilation.
RESULTS: 114 (28%) received surfactant. Surfactant-treated infants had longer LOS (16 ± 11 vs 12 ± 9 days, p < 0.001) compared to non-treated. Infants who received INSURE/LISA (n = 43) had shorter LOS (14 ± 9 vs 18 ± 12 days, p = 0.04) than endotracheal surfactant with prolonged mechanical ventilation (n = 71). Infants who received INSURE/LISA had similar LOS to non-surfactant-treated infants (14 ± 9 vs 13 ± 9 days, p = 0.47).
CONCLUSION: Surfactant administration was associated with longer hospitalization compared to non-treated infants. INSURE/LISA shortened LOS compared to surfactant with prolonged ventilation. In late preterm and early term infants that require surfactant for RDS, less invasive methods reduce LOS.